Is carriership of a balanced translocation or inversion an indication for non-invasive prenatal testing?

Expert Rev Mol Diagn. 2018 Jun;18(6):477-479. doi: 10.1080/14737159.2018.1468255. Epub 2018 Apr 26.

Authors

Malgorzata I Srebniak¹, Ida Vogel^{2

3

4}, Diane Van Opstal¹

Affiliations

¹ a Department of Clinical Genetics , Erasmus Medical Center , Rotterdam , The Netherlands.
² b Departments of Clinical Genetics , Aarhus University Hospital , Aarhus , Denmark.
³ c Center for Prenatal Diagnostics , Aarhus University Hospital , Aarhus , Denmark.
⁴ d Institute of Biomedicine , Aarhus University , Aarhus , Denmark.

PMID: 29676188
DOI: 10.1080/14737159.2018.1468255

No abstract available

Keywords: NIPT; balanced chromosome aberration carrier; indication; invasive testing; prenatal; prenatal screening.

Publication types

Editorial

MeSH terms

Chromosome Disorders / diagnosis*
Chromosome Disorders / genetics*
Chromosome Inversion*
Female
Humans
Male
Prenatal Diagnosis*
Translocation, Genetic*